Journal article · 2025 · Open access
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
The Lancet Oncology, 26(12), 1638–1650 · Published 25 November 2025 · DOI 10.1016/s1470-2045(25)00534-0
In brief
“A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group” is a 2025 journal article by Philipp Karschnia and 48 co-authors, published in The Lancet Oncology. OpenAlex counts 40 citations as of 17 November 2026, which puts it in the top 4% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at The Lancet Oncology.
- Citations
- 40
- Most cited in
- 2026 (36)
- Field-weighted impact
- 14.28
- References
- 31
- Authors
- 49
Abstract
Background The efficacy of resection in IDH -mutant grade 2 gliomas remain controversial since terminology for the extent of resection has been inconsistently applied across studies. We aimed to establish a standardised classification for the extent of resection and assess the association between supramaximal resection and survival across molecular subtypes. Methods In this international, multicentre, retrospective study, patients aged 18 years and older with newly diagnosed grade 2 IDH -mutant glioma were identified from institutional databases across 16 centres in the USA, Europe, and Asia between between Sept 1, 1993, and May 10, 2024. We used Cox proportional hazard regressions to analyse the associations between residual tumour and progression-free survival and overall survival. Patients were stratified according to a previously postulated classification system based on residual tumour volume. A cohort of patients from UCSF diagnosed between Feb 16, 1998, and Nov 14, 2017, was used for geographically and institutionally independent external validation. Findings We identified 1391 patients with newly diagnosed IDH -mutant grade 2 gliomas, with a median follow-up of 81 months (95% CI 78–85). 728 patients (379 with astrocytoma and 349 with oligodendroglioma) received no first-line treatment beyond surgery, allowing us to study the isolated effects of resection. Patients with maximal T2-fluid attenuated inversion recovery (T2-FLAIR) resection (class 2; 0–5 cm 3 remnant) had superior progression-free and overall survival compared with submaximal T2-FLAIR resection (class 3; 5–25 cm 3 remnant) or minimal T2-FLAIR resection (class 4; >25 cm 3 remnant), with 10-year survival rates of 82% (95% CI 76–87) versus 75% (62–84) versus 48% (29–65; p<0·0001) and 5-year progression-free survival rates of 44% (38–50) versus 25% (16–34) versus 12% (4–24; p<0·0001), respectively. Resection beyond T2-FLAIR borders (class 1) provided survival benefits, with a 10-year survival rate of 98% (95% CI 92–99) and a 5-year progression-free survival rate of 83% (76–88) for supramaximal T2-FLAIR resection (class 1). Associations between survival and extensive resection were evident after 3 years in astrocytomas, whereas survival curves separated after 6–8 years in oligodendrogliomas. The prognostic relevance of the four-tier classification was conserved in multivariable analyses, in 625 patients receiving first-line chemotherapy or radiotherapy (with or without chemotherapy), and in the external UCSF cohort of 381 patients with IDH -mutant grade 2 gliomas. Interpretation The proposed RANO classification for extent of resection could serve as a tool for prognostic stratification. Although associations between survival and extensive surgery are evident sooner in patients with astrocytoma, supramaximal resection also translates into survival benefits for patients with oligodendrogliomas. Funding None.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Karschnia, P., Young, J. S., Wijnenga, M. M., Sciortino, T., Teske, N., Corell, A., Wagner, A., Youssef, G., Park, Y. W., Häni, L., Jünger, S. T., Dono, A., Ehret, F., Mireles, E. E. M., Neidert, N. N., Bruno, F., Tuchek, C. A., van der Vaart, T., Rossi, M., . . . Tonn, J. C. (2025). A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group. The Lancet Oncology, 26(12), 1638–1650. https://doi.org/10.1016/s1470-2045(25)00534-0
MLA 9
Karschnia, Philipp, et al. “A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group.” The Lancet Oncology, vol. 26, no. 12, 2025, pp. 1638–1650. https://doi.org/10.1016/s1470-2045(25)00534-0.
Chicago
Karschnia, Philipp, Jacob S. Young, Maarten M.J. Wijnenga, Tommaso Sciortino, Nico Teske, Alba Corell, Arthur Wagner, et al. 2025. “A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group.” The Lancet Oncology 26 (12): 1638–1650. https://doi.org/10.1016/s1470-2045(25)00534-0.
Harvard
Karschnia, P. et al. (2025) ‘A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group’, The Lancet Oncology, 26(12), pp. 1638–1650. doi:10.1016/s1470-2045(25)00534-0.
IEEE
P. Karschnia et al., “A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group,” The Lancet Oncology, vol. 26, no. 12, pp. 1638–1650, 2025, doi: 10.1016/s1470-2045(25)00534-0.
BibTeX
@article{karschnia2025prognostic,
title = {{A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group}},
author = {Karschnia, Philipp and Young, Jacob S. and Wijnenga, Maarten M.J. and Sciortino, Tommaso and Teske, Nico and Corell, Alba and Wagner, Arthur and Youssef, Gilbert and Park, Yae Won and Häni, Levin and Jünger, Stephanie Theresa and Dono, Antonio and Ehret, Felix and Mireles, Eduardo Erasmo Mendoza and Neidert, Nicolas Noel and Bruno, Francesco and Tuchek, Chad A. and van der Vaart, Thijs and Rossi, Marco and Nibali, Marco Conti and Gay, Lorenzo Gabriel and Gramelt, Alfred and Tandon, Nitin and Ahn, Sung Soo and Chang, Jong Hee and Weller, Michael and Vincent, Arnaud J.P.E. and Goldbrunner, Roland and Cahill, Daniel P. and Huang, Raymond Y. and others},
journal = {The Lancet Oncology},
year = {2025},
volume = {26},
number = {12},
pages = {1638--1650},
doi = {10.1016/s1470-2045(25)00534-0},
url = {https://doi.org/10.1016/s1470-2045(25)00534-0}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- IDH-mutant glioma
- extent of resection
- prognostic stratification
- supramaximal resection
- astrocytoma
- oligodendroglioma
- progression-free survival
- overall survival
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Karschnia, P., Young, J. S., Wijnenga, M. M., Sciortino, T., Teske, N., Corell, A., Wagner, A., Youssef, G., Park, Y. W., Häni, L., Jünger, S. T., Dono, A., Ehret, F., Mireles, E. E. M., Neidert, N. N., Bruno, F., Tuchek, C. A., van der Vaart, T., Rossi, M., . . . Tonn, J. C. (2025). A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group. The Lancet Oncology, 26(12), 1638–1650. https://doi.org/10.1016/s1470-2045(25)00534-0
How many times has this paper been cited?
40 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at The Lancet Oncology: sign in and open the full text from this page.
Who wrote this paper?
Philipp Karschnia, Jacob S. Young, Maarten M.J. Wijnenga, Tommaso Sciortino, Nico Teske, Alba Corell, Arthur Wagner, Gilbert Youssef, Yae Won Park, Levin Häni, Stephanie Theresa Jünger, Antonio Dono and 37 more.
What is the DOI of this paper?
10.1016/s1470-2045(25)00534-0, permanently at https://doi.org/10.1016/s1470-2045(25)00534-0. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.